Category: Cancer (Oncology), HIC#13748
Title:
An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women with Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma,(CA225243)
Contact:Meredith Gross
Phone:(434)924-2745
E-mail:mpg8b@virginia.edu

UVa Health System, Obstetrics and Gynecology; Gynecologic Oncology seeks: Women ages 18 years and older with locally advanced or metastatic cervical cancer for research study.

The purpose of the study is to learn what effects the investigational drug cetuximab has when given in combination with cisplatin and radiation therapy for cervical cancer. This study involves taking an experimental medicine, checking vital signs, a physical exam, blood draws, CT or MRI scans, FDG-PET scan, cervical biopsies. There are four visits every week lasting 2-6 hours for 4-6 weeks with follow up visits every three months lasting 2-4 hours for up to five years.


Study-related experimental medication, cervical biopsy and FDG-PET scan provided free of charge.
Participant's insurance company will be billed for standard of care tests and procedures.
No compensation is provided for this study.

Contact Information:
For more information please contact:
" Meredith Gross
" Tel: ( 434) 924-0436 Email:mpg8b
" Insert IRB-HSR # 13748

Principal Investigator: Linda Duska, M.D.
Primary Investigator: Duska Linda,
Department: Obstetrics & Gynecology
 Accepts adult enrollment :YES
Accepts minor enrollment :NO